REMOVAL OF CYTOKINE INDUCING SUBSTANCES BY POLYMYXIN-B IMMOBILIZED POLYSTYRENE-DERIVATIVE FIBERS DURING IN-VITRO HEMOPERFUSION OF 10-PERCENT HUMAN PLASMA CONTAINING STAPHYLOCOCCUS-AUREUS CHALLENGE
Bl. Jaber et al., REMOVAL OF CYTOKINE INDUCING SUBSTANCES BY POLYMYXIN-B IMMOBILIZED POLYSTYRENE-DERIVATIVE FIBERS DURING IN-VITRO HEMOPERFUSION OF 10-PERCENT HUMAN PLASMA CONTAINING STAPHYLOCOCCUS-AUREUS CHALLENGE, ASAIO journal, 44(1), 1998, pp. 48-53
Staphylococcus aureus (S. aureus) is frequently isolated from blood cu
ltures in the hospital setting. The pathogenesis of S. aureus bacterem
ia probably replicates mechanisms implicated in gram negative bacteria
l infections. Cell wall components, such as peptidoglycans and lipotei
choic acids (LTA), can trigger cytokine production. Polymyxin-B (PMX-B
) is a cationic peptide that binds endotoxin (ET) and inhibits its act
ivity. Based on this principle, PMX-B was incorporated in polystyrene-
derivative fibers, creating a hemoperfusion column (PMX-20R) that remo
ves ET. The authors assessed whether S. aureus possesses PMX-B suppres
sible cytokine-inducing substances, and whether LTA, an anionic molecu
le, is one such substance. Heparinized blood was obtained from healthy
volunteers, peripheral blood mononuclear cells (PBMC) were isolated b
y Ficoll-Hypaque separation, and 10% human plasma prepared. PBMC were
incubated with 1, 5, or 10 mu g/ml of S. aureus LTA, with and without
10 mu g/ml of PMX-B. Also, using PMX-20R, in vitro hemoperfusion (IVH)
was performed with 10% human plasma containing 1:1,000 dilution of S.
aureus challenge at 100 ml/min for 2 hours at 37 degrees C, and plasm
a obtained before and after IVH was incubated with PBMC. After a 24 ho
ur incubation at 37 degrees C, PBMC were subjected to three freeze-tha
w cycles, and total TNF alpha was measured by radioimmunoassay. TNF al
pha production by PBMC incubated with LTA was 164 +/- 4 pg, 324 +/- 54
pg, 657 +/- 55 pg, and 1143 +/- 215 pg in control, and LTA 1, 5, and
10 mu g/ml, respectively. The addition of PMX-B resulted in a 40 +/- 1
2% (p = 0.02), 61 +/- 6% (p = 0.002), and 62 +/- 14% (p = 0.02) decrea
se in TNF alpha production, respectively. Before IVH, TNF alpha produc
tion by PBMC incubated with 10% plasma containing S. aureus challenge
was 1275 +/- 70 pg. After 2 hours of IVH, the decrease in TNF alpha pr
oduction was 20 +/- 4% (p = 0.002). In conclusion, S. aureus LTA induc
es TNF alpha production that is significantly suppressed by PMX-B. Con
sequently, S. aureus cytokine-inducing substances are removed during I
VH with PMX-20R, and this may be due to stoichiometric binding of LTA
to PMX-B.